UAE and Indian hospital business Aster DM has tasked bankers to look at a demerger between the two geographies. Chairman Azad Moopen has said this makes more room for capex on the high-growth Indian business.
Pan-European booking platform Docplanner has made its first meaningful internationalisation in four years with the acquisition of German doctor-rating player Jameda. CFO Peter Bialo tells HBI that the recently-minted unicorn will be heading for another fundraising round in a year.
Australia's largest oncology provider Icon Group has been bought by EQT's infrastructure arm for AUS$2.4bn. Its CEO Mark Middleton tells HBI that the group now has its sights set on Europe.
Spain will spend over €450m on the digitalisation of its primary care sector, building a new data network and AI as part of a new €1.5bn healthcare budget. The sector, however, says it is not enough.
Hospital group HCA Healthcare UK is taking on 30 nurse refugees from Lebanon to work in its UK hospitals. Its charity partner wants to roll out the scheme to other private hospitals.
Romania's public hospitals are overrun with COVID patients. The 3,400+ beds owned by the private sector aren't being used for infected patients but instead as an 'overflow' for the otherwise ill. HBI speaks to the CEO of Regina Maria, who says visits to its ER are up 25% and looks at the results of rival Medlife, where revenue is up 57% in the first nine months.
UK homecare group Cera Care is expanding its network with 15 digital healthcare hubs across the UK to deliver telehealth and medication services. The tech-savvy operator will further launch a digital flu tracker and treatment system. HBI talks with Igal Aciman, Chief Commercial Officer at Cera to find out more.
Thailand has re-opened for medical tourists without quarantine as the country seeks to revive its ailing medical tourism sector. We look at the impact that the 18-month ban has had on the country's big hospital groups Bumrungrad International Hospital and Bangkok Dusit Medical Services (BDMS).
US-based pharmacy group McKesson has sold its UK arm - made up of retail pharmacy group Lloyds Pharmacy and a drug distribution business - to Aurelius, an investor specialised in turnarounds. The new owner is likely to focus on the rationalisation of the business, HBI hears.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
